Ingersoll Rand Slips Into Earnings With Options the Most Defensive Signal
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Ingersoll Rand reports third-quarter results on October 29, down 5.5% over the past week to $73.48 while close peers moved an average of roughly flat, making the recent underperformance the sharpest feature of the setup heading into Wednesday's print.
The clearest positioning signal is in options, not short interest. The put/call ratio has edged to 0.30, about 1.7 standard deviations above its 20-day average of 0.26. That is not an extreme reading in absolute terms, but the move is notable because it has been creeping higher for two weeks in a row, from a base well below 0.25 in late September. The 52-week high on the PCR is 1.04, so there is plenty of room for additional hedging, but the direction of travel has turned more cautious. The lending market, by contrast, gives no signal at all: borrow availability is exceptionally loose at 3,661% (roughly 36 shares available for every one currently lent out), cost to borrow has fallen 29% over the past week to just 0.39%, and short interest at 3.4% of the free float is a modest position that has actually edged down over the past week after rising about 16% through the course of October. The borrow market is telling a different story from the options market, one of indifference rather than concern.
The analyst community is broadly constructive but has spent much of 2026 trimming targets. Several firms cut their numbers after the Q2 report in April and again in late July, though Evercore ISI and Baird both raised targets following the last print in August, to $93 and $109 respectively. The mean target now sits at $94, implying roughly 28% above the current price. The debate centres on margins. Bears point to the Q2 EBITDA margin contraction to 28.6% from 29.7% a year earlier, the guidance cut on organic sales due to lower tariff-related pricing, and an 11.4% stock decline on that day. Bulls counter with a book-to-bill ratio above 1.0, strong order growth in the Americas and Asia-Pacific, and a 16% backlog increase that provides a buffer for the second half. Morgan Stanley, which cut its target to $80 in June, sits well below the pack, while Citigroup and Barclays maintain positive ratings even after their own target reductions.
One ownership shift is worth noting. Capital International Investors, part of the Capital Group complex, disclosed a drop in its stake from 12.9% to 4.0% in a March 13G/A filing. Meanwhile, T. Rowe Price Associates lifted its disclosed position from 5.2% to 6.9% as of August. These are event-driven disclosures around the 5% threshold and stakes can change materially without a further filing, but the divergence within large institutional holders reflects the split in conviction the analyst targets already suggest. Wikipedia traffic for Ingersoll Rand is running at a z-score of 2.4 against its own 90-day history, meaning retail attention has picked up materially in the week before the release.
Wednesday's print will test whether the company can demonstrate that margin pressure from the second quarter was temporary, and whether the backlog and order momentum it has cited are translating into revenue in a quarter where the stock has already priced in some disappointment.
Stocks in this article
See the live data behind this article on ORTEX.
Open IR on ORTEX →How this article was generated
- Generated
- 26 Oct 2026, 04:28
- Data as of
- 26 Oct 2026, 04:02
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.